Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

Season 40 is also expected to become available to stream on Paramount Plus, joining the previous two seasons, but as of publication, we don’t know when that will happen. Additionally, we also ...

Rugby league personality Mark ‘MG’ Geyer is joining Sydney’s 2GB and Nine Radio on a three-year deal. The NSW and Australian representative and NRL premiership winner will be heard daily on 2GB’s new ...

The European Commission's decision on approval is expected in the second half of January 2025. Eylea is used to treat neovascular age-related macular degeneration and other severe retinal diseases.

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...

The MG M9 has stolen the spotlight at Auto Expo 2025. With its futuristic design, opulent interiors, and feature-packed cabin, this premium MPV is the epitome of luxury. Let’s dive into the ...

Read More About MG MG4 MG's most popular car gets powerful hybrid makeover: 2025 MG ZS revealed ahead of imminent Australian release for Toyota Corolla Cross and GWM Haval Jolion rival MG stuns with ...

Speculating about pricing, MG Majestor could be offered at a starting price of around Rs 40 lakh. Top variants could be priced around Rs 45 lakh. In comparison, the Gloster is available in the ...

Your browser does not support the audio element. JSW MG Motor India has showcased the M9 MPV at the ongoing Auto Expo 2025. This will be the second product sold via ...

Investing.com -- UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to "Neutral" from "Buy" given uncertainty around its key Eylea franchise. Brokerage slashed price target to $738 ...